PDCD1LG2 and neoplasm: By inhibiting the binding of PD-1 to its ligands PD-L1/PD-L2, expressed on various cell subsets including tumor cells and other cell types in the ex vivo cultures, the functionality of T-cells was found to increase, as assessed by the release of several important effector molecules (Figures 3 and 4).